Access cutting-edge acute myeloid leukemia treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.
Access acute myeloid leukemia specialists in Stanford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related acute myeloid leukemia treatment provided free
This study will compare the effects of Quizartinib versus placebo in combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute myeloid leukemia (AML).
Sponsor: Daiichi Sankyo
Check if you qualify for this acute myeloid leukemia clinical trial in Stanford, CA
If you're searching for acute myeloid leukemia treatment options in Stanford, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced acute myeloid leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.